Genemarkers has seen a surge in business due to COVID-19 testing.
KALAMAZOO, Mich.—The expansion of COVID-19 testing, while playing a large part in pandemic mitigation strategies across Michigan, also fueled genomics research company Genemarkers' exponential growth. It's an accomplishment being celebrated by the Biosciences Research and Commercialization Center (BRCC) of Western Michigan University—a nonprofit that invests in early stage life science startups across the state.
Genemarkers, which applies state-of-the-art genomics technologies to research and development, initially formed a solid foundation in the skin care industry before diversifying into clinical genetic testing. The company found itself uniquely positioned to make a pandemic pivot when novel coronavirus cases began surging in the spring of 2020.